Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

PDA/NPA

Rebalancing Board asked to adopt patient safety 'pledge'

The Pharmacists’ Defence Association and National Pharmacy Association are jointly calling on the Department of Health’s Rebalancing Board to ensure that pharmacists become more, rather than less, accessible to the public.

The Department of Health’s Rebalancing Board is being urged to adopt a patient safety “pledge” by two bodies representing community pharmacists.

The Pharmacists’ Defence Association (PDA) and National Pharmacy Association (NPA) have released a statement calling on the Rebalancing Board to consider the pledge at its next meeting on 23 October 2017.

The statement says that any proposals on pharmacy supervision developed by the Board should be presented to the Secretary of State for Health only when certain circumstances are met, one of which is “compelling evidence” that the changes will not risk a reduction in patient safety.

It also says there should be a clear case that any proposed changes “will make pharmacists more, rather than less, accessible to the public”.

The statement calls for a “clear view” among both pharmacists and patient representative groups about the way forward on pharmacy supervision, and says there should be the “widest possible engagement with front-line community pharmacists and pharmacy technicians” who would need to implement any changes.

The Rebalancing Medicines Legislation and Pharmacy Regulation Programme Board has been tasked with looking at a more modern, risk-based regulatory approach to pharmacy.

In September, a leaked document, prepared by a working group of the board suggested that current legislation could be changed to allow a ‘registered pharmacy professional’, which could include a pharmacy technician, to ‘take responsibility for’ the sale and supply of pharmacy and prescription-only medicines.

NPA Chair, Ian Strachan, said: “The consequences of making the wrong policy choices [on pharmacy supervision] would be grave for the patients that pharmacies serve.

“It ought to be very easy and uncontroversial to give a basic assurance on patient safety, and we hope all members of the Board will feel able to do this.”

Pharmacists’ Defence Association Chairman, Mark Koziol, added: “Any changes must make the pharmacist more available to the public in the community pharmacy setting and not less so.

“Within this vision, pharmacists can enjoy an enhanced professional role and the ability to further develop their clinical relationship with patients.”

Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2017.20203775

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Supplementary images

  • mark koziol Pharmacists’ Defence Association chairman

Jobs you might like

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.